Role of Biomarkers in the Management of Immune-Checkpoint Inhibitor-Related Myocarditis.

Vasbinder, Alexi; Ismail, Anis; Salem, Joe-Elie; Hayek, Salim S

Vasbinder, Alexi; Ismail, Anis; Salem, Joe-Elie; Hayek, Salim S.

Afiliação

Vasbinder A; Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan, Frankel Cardiovascular Center, 1500 E Medical Center Dr, CVC #2709, Ann Arbor, MI, 48109, USA.
Ismail A; Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan, Frankel Cardiovascular Center, 1500 E Medical Center Dr, CVC #2709, Ann Arbor, MI, 48109, USA.
Salem JE; Department of Pharmacology and Clinical Investigation Centre, Pitié-Salpetriere Hospital, Sorbonne Universite, Paris, France.
Hayek SS; Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan, Frankel Cardiovascular Center, 1500 E Medical Center Dr, CVC #2709, Ann Arbor, MI, 48109, USA. shayek@med.umich.edu.

Curr Cardiol Rep ; 25(9): 959-967, 2023 09.

Article em En | MEDLINE | ID: mdl-37436648

Assuntos

Antineoplásicos Imunológicos; Miocardite; Humanos; Miocardite/induzido quimicamente; Miocardite/diagnóstico; Inibidores de Checkpoint Imunológico/uso terapêutico; Creatinina/uso terapêutico; Troponina

Palavras-chave

BNP; CPK; ICI; Myositis; Troponin; irAE

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antineoplásicos Imunológicos / Miocardite Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google